PL399493A1 - Kwasy bisfosfonowe do leczenia i profilaktyki osteoporozy - Google Patents

Kwasy bisfosfonowe do leczenia i profilaktyki osteoporozy

Info

Publication number
PL399493A1
PL399493A1 PL399493A PL39949303A PL399493A1 PL 399493 A1 PL399493 A1 PL 399493A1 PL 399493 A PL399493 A PL 399493A PL 39949303 A PL39949303 A PL 39949303A PL 399493 A1 PL399493 A1 PL 399493A1
Authority
PL
Poland
Prior art keywords
osteoporosis
prevention
treatment
bisphosphonic acids
bisphosphonic
Prior art date
Application number
PL399493A
Other languages
English (en)
Inventor
Frieder Bauss
Bernhard Pichler
Stephen Turley
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29414669&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL399493(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL399493A1 publication Critical patent/PL399493A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
PL399493A 2002-05-10 2003-05-02 Kwasy bisfosfonowe do leczenia i profilaktyki osteoporozy PL399493A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02010136 2002-05-10

Publications (1)

Publication Number Publication Date
PL399493A1 true PL399493A1 (pl) 2012-11-05

Family

ID=29414669

Family Applications (2)

Application Number Title Priority Date Filing Date
PL399493A PL399493A1 (pl) 2002-05-10 2003-05-02 Kwasy bisfosfonowe do leczenia i profilaktyki osteoporozy
PL03371346A PL371346A1 (pl) 2002-05-10 2003-05-02 Kwasy bisfosfonowe do leczenia i profilaktyki osteoporozy

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL03371346A PL371346A1 (pl) 2002-05-10 2003-05-02 Kwasy bisfosfonowe do leczenia i profilaktyki osteoporozy

Country Status (32)

Country Link
US (5) US7410957B2 (pl)
EP (4) EP1506041B1 (pl)
JP (5) JP2005522526A (pl)
KR (7) KR20140021045A (pl)
CN (2) CN100551377C (pl)
AR (2) AR039978A1 (pl)
AT (1) ATE376444T1 (pl)
AU (2) AU2003229770B2 (pl)
BR (1) BR0308901A (pl)
CA (2) CA2481142C (pl)
CY (2) CY1108105T1 (pl)
DE (1) DE60317061T2 (pl)
DK (2) DK1506041T3 (pl)
EC (1) ECSP045335A (pl)
ES (2) ES2294277T3 (pl)
GT (1) GT200300107A (pl)
HR (1) HRP20040906B1 (pl)
IL (3) IL164371A0 (pl)
MX (1) MXPA04009586A (pl)
MY (2) MY146809A (pl)
NO (2) NO328734B1 (pl)
NZ (2) NZ535705A (pl)
PA (1) PA8573101A1 (pl)
PE (1) PE20040440A1 (pl)
PL (2) PL399493A1 (pl)
PT (2) PT1506041E (pl)
RU (2) RU2387451C2 (pl)
SI (2) SI1880744T1 (pl)
TW (1) TWI347188B (pl)
UY (1) UY27802A1 (pl)
WO (1) WO2003095029A1 (pl)
ZA (1) ZA200407950B (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) * 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US20050070504A1 (en) * 2001-12-21 2005-03-31 The Procter & Gamble Co. Risedronate compositions and their methods of use
HUP0402267A3 (en) * 2001-12-21 2007-05-29 Procter & Gamble Method for treatment of bone disorders
AU2003226148A1 (en) * 2002-04-05 2003-10-27 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
KR20140021045A (ko) * 2002-05-10 2014-02-19 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
NZ536273A (en) † 2002-12-20 2007-08-31 Hoffmann La Roche High dose ibandronate formulation
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
DE602005025977D1 (de) * 2004-08-23 2011-03-03 Teva Pharma Kristalline form des ibandronat-natriums und herstellungsverfahren dafür
JP5828607B2 (ja) * 2005-02-01 2015-12-09 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ イバンドロネート多形ｂ
KR100908529B1 (ko) * 2005-02-01 2009-07-20 에프. 호프만-라 로슈 아게 이반드로네이트 다형체 에이
US20070049557A1 (en) * 2005-08-24 2007-03-01 Hashim Ahmed Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
WO2007117706A2 (en) * 2006-04-07 2007-10-18 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
MX2008013468A (es) 2006-04-20 2008-10-30 Hoffmann La Roche Nuevos derivados de diazepano.
US20100120723A1 (en) * 2006-12-20 2010-05-13 Mostafa Akbarieh Pharmaceutical composition comprising a hot-melt granulated lubricant
CN102046192B (zh) * 2008-05-07 2014-11-19 默里昂研究Ⅲ有限公司 GnRH相关化合物的组合物及制备方法
EP2210596A1 (en) 2009-01-22 2010-07-28 Laboratorios Liconsa, S.A. Pharmaceutical composition of ibandronate sodium salt or a hydrate thereof
WO2010099255A1 (en) * 2009-02-25 2010-09-02 Merrion Research Iii Limited Composition and drug delivery of bisphosphonates
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
DK2459176T3 (en) * 2009-07-31 2017-12-04 Gruenenthal Gmbh Crystallization process and bioavailability
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) * 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
WO2012094598A2 (en) 2011-01-07 2012-07-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
JP5874545B2 (ja) * 2011-06-20 2016-03-02 アステラス製薬株式会社 経口投与用医薬組成物
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
CN107011380A (zh) * 2016-01-28 2017-08-04 臧伟 一种二膦酸衍生物及含二膦酸衍生物的组合物治疗骨折的应用
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability
CN114230610B (zh) * 2021-11-26 2023-05-23 西南医科大学附属医院 放射性标记物、其前体化合物、及制法和应用

Family Cites Families (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US124314A (en) * 1872-03-05 Improvement in preparing paper for buildings
US500937A (en) * 1893-07-04 Conduit railway insulator
DE2405254C2 (de) 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE2534391C2 (de) 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
DE2745083C2 (de) 1977-10-07 1985-05-02 Henkel KGaA, 4000 Düsseldorf Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
US4252742A (en) 1979-07-13 1981-02-24 Ciba-Geigy Corporation Chemical process for the preparation of 2,6-dialkylcyclohexylamines from 2,6-dialkylphenols
DE2943498C2 (de) 1979-10-27 1983-01-27 Henkel KGaA, 4000 Düsseldorf Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure
DE3016289A1 (de) 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
IT1201087B (it) 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
FR2531088B1 (fr) 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
US4509612A (en) 1982-09-28 1985-04-09 Applied Power Inc. Latch mechanism for a tilt-cab truck
JPS59145179A (ja) 1983-01-11 1984-08-20 Ricoh Co Ltd 補充交換用部品を検知可能にした事務機器
IT1195993B (it) 1984-01-12 1988-11-03 Gentili Ist Spa Forme farmaceutiche a base di difosfonati
DE3428524A1 (de) 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3434667A1 (de) 1984-09-21 1986-04-03 Henkel KGaA, 4000 Düsseldorf 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung
IT1196315B (it) 1984-10-29 1988-11-16 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici
US4812311A (en) 1984-12-21 1989-03-14 The Procter & Gamble Company Kit for use in the treatment of osteoporosis
DE3512536A1 (de) 1985-04-06 1986-10-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeure-derivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4761406A (en) 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE3540150A1 (de) 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3626058A1 (de) 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3640938A1 (de) 1986-11-29 1988-06-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel
US4973576A (en) 1987-03-10 1990-11-27 Yamanouchi Pharmaceutical Co., Ltd. Bisphophonic acid derivatives and pharmaceutical compositions containing the same
CA1339805C (en) 1988-01-20 1998-04-07 Yasuo Isomura (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active
DE3822650A1 (de) 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4958839A (en) 1988-07-12 1990-09-25 Guzik Technical Enterprises, Inc. Disc clamp employing resilient cone for spreading balls
DE3825654A1 (de) * 1988-07-28 1990-02-01 Bosch Gmbh Robert Sicherheitseinrichtung an einer handwerkzeugmaschine
JP2691914B2 (ja) 1988-09-09 1997-12-17 株式会社リコー 画像形成装置
US5018651A (en) 1988-12-27 1991-05-28 Hull Harold L Side or end dump article carrier
US4922077A (en) 1989-01-31 1990-05-01 Raytheon Company Method of laser marking metal packages
DE3917153A1 (de) * 1989-05-26 1990-11-29 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4922007A (en) 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
JP2985205B2 (ja) 1990-01-25 1999-11-29 ミノルタ株式会社 画像形成装置
JPH03226767A (ja) 1990-01-31 1991-10-07 Minolta Camera Co Ltd 画像形成装置管理システム
US5335048A (en) 1990-01-30 1994-08-02 Minolta Camera Kabushiki Kaisha Efficient control system of image forming apparatus
US5356887A (en) 1990-01-31 1994-10-18 Merck & Co., Inc. Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids
US5019651A (en) 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
JPH04151765A (ja) 1990-10-16 1992-05-25 Fujitsu Ltd ファクシミリ装置の消耗品自動発注方式
AU661080B2 (en) * 1991-11-22 1995-07-13 Warner Chilcott Company, Llc Risedronate delayed-release compositions
CZ282889B6 (cs) * 1991-12-17 1997-11-12 Procter And Gamble Pharmaceuticals, Inc. Použití difosfonátů a parathormonu pro výrobu léčiva, které se používá pro léčení osteoporosy
JPH05224479A (ja) 1992-02-10 1993-09-03 Toshiba Corp 画像形成装置
TW237386B (pl) 1992-04-15 1995-01-01 Ciba Geigy
HUT70210A (en) 1992-06-30 1995-09-28 Procter & Gamble Pharma Use of phosphonates for the treatment of osteoporosis
JPH06111039A (ja) 1992-09-25 1994-04-22 Toray Ind Inc 光学読み取り識別マークの記録方法
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
JPH06250802A (ja) 1993-02-22 1994-09-09 Ricoh Co Ltd プリンタ
FR2703590B1 (fr) 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5510517A (en) * 1993-08-25 1996-04-23 Merck & Co., Inc. Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
JPH07239825A (ja) 1994-02-28 1995-09-12 Canon Inc 状態通報方法およびそれを用いたネットワークシステム
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US5462932A (en) 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
JPH07325514A (ja) 1994-05-30 1995-12-12 Ricoh Co Ltd サプライ発注システム
TW398975B (en) * 1994-07-22 2000-07-21 Lilly Co Eli Pharmaceutical composition for inhibiting bone loss
JPH08152814A (ja) 1994-11-30 1996-06-11 Mita Ind Co Ltd 画像形成装置の管理システム
JPH08152825A (ja) 1994-11-30 1996-06-11 Mita Ind Co Ltd 画像形成装置の管理システム
FR2727629A1 (fr) 1994-12-06 1996-06-07 Sanofi Sa Trousse pour cycle de traitement de l'osteoporose
JP3261900B2 (ja) 1994-12-13 2002-03-04 村田機械株式会社 ファクシミリ装置
WO1996019998A1 (en) 1994-12-28 1996-07-04 Gador S.A. Bone mass anabolic composition comprising olpadronate
JPH08211792A (ja) 1995-02-03 1996-08-20 Mita Ind Co Ltd 画像形成装置の管理システム
KR19980702210A (ko) * 1995-02-17 1998-07-15 폴락 돈나 엘 비척추골 골절의 위험률을 감소시키는 방법
US20010051616A1 (en) 1995-02-17 2001-12-13 David B. Karpf Method of lessening the risk of vertebral fractures
JPH08315052A (ja) 1995-05-18 1996-11-29 Ricoh Co Ltd 自動発注システム
JPH08310007A (ja) 1995-05-19 1996-11-26 Oki Data:Kk シリアルプリンタ
JPH09120238A (ja) 1995-10-25 1997-05-06 Canon Inc 出力装置
JPH09156123A (ja) 1995-12-04 1997-06-17 Brother Ind Ltd プリンタ
JPH09185474A (ja) 1995-12-27 1997-07-15 Fuji Xerox Co Ltd 印刷管理装置
JP3363680B2 (ja) 1995-12-28 2003-01-08 ブラザー工業株式会社 カートリッジの真偽判別方法及びそれを利用した出力装置
JPH09259355A (ja) 1996-03-21 1997-10-03 Oki Electric Ind Co Ltd 梱包された商品の確認処理システム
DE19615812A1 (de) 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
US5930553A (en) 1997-04-25 1999-07-27 Hewlett-Packard Company Image forming and office automation device consumable with memory
US5730715A (en) 1996-06-14 1998-03-24 Becton Dickinson And Company Method for the iontophoretic administration of bisphosphonates
JPH1052964A (ja) 1996-08-09 1998-02-24 Canon Inc 画像形成装置および画像形成装置の消耗材管理方法
JP3266002B2 (ja) 1996-08-29 2002-03-18 オムロン株式会社 純正交換部品識別装置及び純正交換部品識別方法
JPH10105011A (ja) 1996-09-25 1998-04-24 Ricoh Co Ltd 記録出力サービス課金装置
US5781405A (en) * 1996-09-30 1998-07-14 Gateway 2000, Inc. Electronic device having rotatably mounted infrared device with a pair of pegs fitting into a pair of holes
JPH10234825A (ja) 1997-02-20 1998-09-08 Cosmo Yakuhin:Kk 配置薬箱システム
JPH10264968A (ja) 1997-03-26 1998-10-06 Funai Electric Co Ltd 梱包構造
US6572874B1 (en) 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6905701B2 (en) 1997-06-11 2005-06-14 Umd, Inc. Formulations for transmucosal vaginal delivery of bisphosphonates
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
EP0998292B1 (en) * 1997-07-22 2001-11-21 Merck & Co., Inc. (a New Jersey corp.) Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US6015801A (en) 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
JPH1185657A (ja) 1997-09-10 1999-03-30 Toshiba Corp サーバクライアントシステム及びカード作成装置の消耗品集中管理システム
US6124314A (en) 1997-10-10 2000-09-26 Pfizer Inc. Osteoporosis compounds
SE9703691D0 (sv) 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
JPH11126008A (ja) 1997-10-24 1999-05-11 Canon Inc カートリッジおよびリサイクルシステム
JPH11239926A (ja) 1997-12-22 1999-09-07 Canon Inc 部品の再利用システム及び分解を容易にした製品及び分解方法
JP3065053B2 (ja) 1998-01-06 2000-07-12 セイコーエプソン株式会社 機器監視システム、ローカル監視装置、統合監視装置、機器監視方法、及び、プログラムを格納したコンピュータ可読媒体
JP4274332B2 (ja) 1998-02-20 2009-06-03 東芝テック株式会社 画像形成装置
JPH11272350A (ja) 1998-03-20 1999-10-08 Canon Inc 課金管理装置及び方法及び印刷装置
JP3919375B2 (ja) 1998-03-20 2007-05-23 キヤノン株式会社 画像形成装置及び画像形成装置の制御方法
JP3720584B2 (ja) 1998-06-05 2005-11-30 株式会社リコー 事務機器の管理システムとそのホストコンピュータ
WO1999067809A1 (en) 1998-06-24 1999-12-29 Merck & Co., Inc. Compositions and methods for inhibiting bone resorption
JP2000019803A (ja) 1998-07-01 2000-01-21 Canon Inc 消耗品ユニット及びこれを用いた画像形成装置及びその再利用システムとその方法
US6816968B1 (en) 1998-07-10 2004-11-09 Silverbrook Research Pty Ltd Consumable authentication protocol and system
JP3200037B2 (ja) 1998-07-16 2001-08-20 株式会社ダスキン レンタル商品管理システム
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
JP3476122B2 (ja) 1998-08-26 2003-12-10 株式会社沖データ 状態通知装置
JP2968791B1 (ja) 1998-08-28 1999-11-02 新潟日本電気株式会社 印刷システム
US6494562B1 (en) 1998-09-03 2002-12-17 Hewlett-Packard Company Method and apparatus for identifying a sales channel
FR2784031B1 (fr) * 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
EP0998932A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
EP0998933A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
JP2000206752A (ja) 1998-11-10 2000-07-28 Ricoh Co Ltd 電子写真記録装置
US6331533B1 (en) 1998-11-16 2001-12-18 Merck & Co., Inc. Method for inhibiting dental resorptive lesions
AU756540B2 (en) 1998-12-04 2003-01-16 Roche Diagnostics Gmbh Use of ibandronate for promoting osseointegration of endoprostheses
US6229655B1 (en) * 1998-12-22 2001-05-08 Minolta Co., Ltd. Zoom lens system
JP2000194767A (ja) 1998-12-24 2000-07-14 Ricoh Co Ltd 自動発注システム
JP4297579B2 (ja) 1998-12-28 2009-07-15 日立マクセル株式会社 管理システム
KR100415490B1 (ko) * 1999-01-11 2004-01-24 프라운호퍼-게젤샤프트 츄어 푀르더룽 데어 안게반텐 포르슝에.파우. 파워 모스 소자 및 그 제조 방법
US6204763B1 (en) 1999-03-22 2001-03-20 Jujitsu Limited Household consumable item automatic replenishment system including intelligent refrigerator
DK1165184T3 (da) 1999-04-09 2004-04-13 Karobio Ab Estrogenreceptor-beta antagonisme og knoglesygdomme
SE9901272D0 (sv) 1999-04-09 1999-04-09 Astra Ab New improved formulation
CA2308532C (en) 1999-05-12 2005-11-29 Gador S.A. Use of bisphosphonates for the treatment of osteogenesis imperfecta
DK1178810T3 (da) 1999-05-21 2005-07-11 Novartis Ag Anvendelse af bisphosphonsyrer til behandling af angiogenese
JP2000347503A (ja) 1999-06-04 2000-12-15 Nec Corp 記録装置、記録装置におけるトナーカートリッジの適合性判別方法及びトナーカートリッジ
US6965411B1 (en) 1999-06-24 2005-11-15 Jones Richard A Remote camera positioner
AR024462A1 (es) 1999-07-01 2002-10-02 Merck & Co Inc Tabletas farmaceuticas
US6903836B2 (en) 1999-09-10 2005-06-07 Hewlett-Packard Development Company, L.P. Hard copy cost recovery systems, an apparatus for tracking usage information for a hard copy device, hard copy devices, and a usage accounting method
US6458387B1 (en) 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
JP2001246822A (ja) 1999-12-27 2001-09-11 Canon Inc 印刷装置、印刷装置における報知方法、印刷装置の制御方法、外部装置、外部装置の制御方法、及び記録媒体
US6285060B1 (en) * 1999-12-30 2001-09-04 Siliconix Incorporated Barrier accumulation-mode MOSFET
JP2000325554A (ja) 2000-01-01 2000-11-28 Samii Kk スロットマシン
JP2001228762A (ja) 2000-02-14 2001-08-24 Canon Inc 消耗品管理システム及び消耗品管理方法
JP2001228761A (ja) 2000-02-14 2001-08-24 Canon Inc 消耗品管理方法及び消耗品管理システム
JP2001253827A (ja) 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法
JP3799210B2 (ja) 2000-03-07 2006-07-19 株式会社リコー 画像形成装置
US20020004218A1 (en) * 2000-03-31 2002-01-10 Rodan Gideon A. Methods for identifying compounds useful for inhibiting geranylgeranyl diphosphate synthase
WO2001076592A1 (en) 2000-04-06 2001-10-18 Acorda Therapeutics, Inc. Compositions and methods for promoting neural regeneration
US6468559B1 (en) * 2000-04-28 2002-10-22 Lipocine, Inc. Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
JP3302985B2 (ja) 2000-05-12 2002-07-15 株式会社ハイパーマーケティング 消耗品提供システム
GB0012209D0 (en) 2000-05-19 2000-07-12 Novartis Ag Organic compounds
US8052987B2 (en) 2000-06-20 2011-11-08 Novartis Pharmaceuticals Corporation Method of administering bisphosphonates
US6476006B2 (en) 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
KR100863146B1 (ko) 2000-07-17 2008-10-14 아스텔라스세이야쿠 가부시키가이샤 경구 흡수 개선 의약 조성물
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
CA2424729A1 (en) 2000-10-19 2002-04-25 Merck & Co., Inc. Estrogen receptor modulators
US6750213B2 (en) 2000-10-19 2004-06-15 Merck & Co., Inc. Estrogen receptor modulators
DE60111574T2 (de) 2001-01-23 2006-05-11 Gador S.A. Bisphosphonate enthaltende Zusammensetzungen zur Vorbeugung und/oder Heilung von metabolischen Knochenkrankheiten, Verfahren zu ihrer Herstellung und Benutzung dieser Zusammensetzungen
AR034199A1 (es) 2001-02-01 2004-02-04 Riderway Corp Composicion farmacologica liquida para el tratamiento de enfermedades oseas y procedimientos para su elaboracion
PL361909A1 (pl) 2001-02-06 2004-10-04 The Royal Alexandra Hospital For Children Lek do leczenia osteonekrozy i prowadzenia pacjentów u których występuje ryzyko rozwoju osteonekrozy
NZ527157A (en) 2001-03-01 2005-04-29 Emisphere Tech Inc Compositions for delivering bisphosphonates
CA2445922A1 (en) 2001-05-10 2002-11-21 Merck & Co., Inc. Estrogen receptor modulators
US6998678B2 (en) * 2001-05-17 2006-02-14 Infineon Technologies Ag Semiconductor arrangement with a MOS-transistor and a parallel Schottky-diode
US20030139378A1 (en) 2001-12-13 2003-07-24 Daifotis Anastasia G. Liquid bisphosphonate formulations for bone disorders
US20050070504A1 (en) 2001-12-21 2005-03-31 The Procter & Gamble Co. Risedronate compositions and their methods of use
HUP0402267A3 (en) * 2001-12-21 2007-05-29 Procter & Gamble Method for treatment of bone disorders
DE10262418B3 (de) * 2002-02-21 2015-10-08 Infineon Technologies Ag MOS-Transistoreinrichtung
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
KR100938136B1 (ko) * 2002-03-13 2010-01-22 머크 앤드 캄파니 인코포레이티드 안드로겐 수용체 조정자로서의 불화된 4-아자스테로이드 유도체 및 이를 포함하는 약제학적 조성물
AU2003226148A1 (en) 2002-04-05 2003-10-27 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
KR20140021045A (ko) 2002-05-10 2014-02-19 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
NZ536273A (en) 2002-12-20 2007-08-31 Hoffmann La Roche High dose ibandronate formulation
GB0424543D0 (en) * 2004-11-05 2004-12-08 Varintelligent Bvi Ltd Driving method for high frame rate display system

Also Published As

Publication number Publication date
ES2294277T3 (es) 2008-04-01
RU2387451C2 (ru) 2010-04-27
BR0308901A (pt) 2005-01-04
AU2010200438A1 (en) 2010-02-25
UY27802A1 (es) 2003-11-28
GT200300107A (es) 2006-02-23
MXPA04009586A (es) 2005-01-11
EP2851105A1 (en) 2015-03-25
US20080249069A1 (en) 2008-10-09
KR20140021045A (ko) 2014-02-19
SI1506041T1 (sl) 2008-02-29
EP2308563A1 (en) 2011-04-13
US7718634B2 (en) 2010-05-18
AR039978A1 (es) 2005-03-09
DE60317061D1 (de) 2007-12-06
PT1880744E (pt) 2015-02-13
US20050075319A1 (en) 2005-04-07
US20060166938A1 (en) 2006-07-27
US7410957B2 (en) 2008-08-12
AU2003229770A1 (en) 2003-11-11
JP2015083592A (ja) 2015-04-30
PT1506041E (pt) 2007-12-28
KR100642961B1 (ko) 2006-11-10
ZA200407950B (en) 2005-12-28
ATE376444T1 (de) 2007-11-15
NO328734B1 (no) 2010-05-03
JP2009132709A (ja) 2009-06-18
WO2003095029A1 (en) 2003-11-20
HK1080409A1 (zh) 2006-04-28
KR20090106663A (ko) 2009-10-09
JP5837552B2 (ja) 2015-12-24
MY146809A (en) 2012-09-28
US20030225039A1 (en) 2003-12-04
PE20040440A1 (es) 2004-08-07
IL164371A0 (en) 2005-12-18
AR061845A2 (es) 2008-09-24
KR20040097267A (ko) 2004-11-17
KR20090029312A (ko) 2009-03-20
CA2763775A1 (en) 2003-11-20
NO331024B1 (no) 2011-09-12
EP1880744B1 (en) 2015-01-21
ECSP045335A (es) 2004-11-26
AU2010200438B2 (en) 2012-02-02
RU2004129324A (ru) 2006-01-27
JP2013166773A (ja) 2013-08-29
JP2014058554A (ja) 2014-04-03
CN1646193A (zh) 2005-07-27
EP1506041B1 (en) 2007-10-24
CY1116233T1 (el) 2017-02-08
DE60317061T2 (de) 2008-07-24
EP1880744A1 (en) 2008-01-23
PL371346A1 (pl) 2005-06-13
HRP20040906A2 (en) 2005-06-30
KR20150053811A (ko) 2015-05-18
DK1880744T3 (en) 2015-02-09
CN100551377C (zh) 2009-10-21
TWI347188B (en) 2011-08-21
NZ556278A (en) 2009-06-26
KR20060058151A (ko) 2006-05-29
JP5813911B2 (ja) 2015-11-17
DK1506041T3 (da) 2008-01-28
CA2481142C (en) 2012-11-13
NO20044195L (no) 2004-10-01
IL164371A (en) 2010-11-30
CN1939314A (zh) 2007-04-04
MY140080A (en) 2009-11-30
JP6067466B2 (ja) 2017-01-25
CY1108105T1 (el) 2014-02-12
CA2763775C (en) 2014-01-07
ES2532393T3 (es) 2015-03-26
KR20120065435A (ko) 2012-06-20
HRP20040906B1 (en) 2013-01-31
SI1880744T1 (sl) 2015-04-30
CA2481142A1 (en) 2003-11-20
AU2003229770B2 (en) 2009-11-05
NZ535705A (en) 2007-08-31
EP1506041A1 (en) 2005-02-16
TW200404553A (en) 2004-04-01
RU2008103617A (ru) 2009-08-10
PA8573101A1 (es) 2004-02-07
KR100642961B9 (ko) 2021-11-12
IL205262A (en) 2015-03-31
US20100197637A1 (en) 2010-08-05
US7192938B2 (en) 2007-03-20
NO20100477L (no) 2004-10-01
JP2005522526A (ja) 2005-07-28
RU2329809C2 (ru) 2008-07-27

Similar Documents

Publication Publication Date Title
SI1880744T1 (sl) Bifosfonske kisline za zdravljenje in prepreäśevanje osteoporoze
PL364995A1 (pl) Sposób leczenia lub zapobiegania infekcjom wywołanym przez Flavivirus przy użyciu analogów nukleozydów
IL241920A0 (en) A method for treating multiple sclerosis
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL165950A0 (en) Compositions and method for the diagnosis and treatment of tumor
AU2003263760A1 (en) Methods for the treatment or prevention of obesity
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
AU2003211610A1 (en) Pharmaceutical compositions for the treatment or prevention of osteoporosis
GB0213869D0 (en) The treatment of pain
AU2003292045A8 (en) Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
AU2003268939A1 (en) Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
IL162053A0 (en) Method for the treatment of bone disorders
GB0201025D0 (en) The treatment of degenerative diseases
EP1573063A4 (en) TREATMENT OF LIVER DISEASES
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
IL162492A0 (en) Use of alkylphosphocholines for the preventative treatment of protozoandiseases
GB0100092D0 (en) Treatment of degenerative diseases
HUP0203741A3 (en) Treatment of osteoporosis
TJ20010676A (en) Method treatment cirrosis of the liver
AU2003245211A1 (en) Treatment of osteoporosis
IL151658A0 (en) Methods and compositions for the treatment or prevention of cardiovascular diseases
AU2002366591A8 (en) Method of administering calcium citrate
SI1175904T1 (sl) Alendronat za rabo pri zdravljenju osteoporoze
GB0120784D0 (en) The treatment of liver disease